Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001971:Bromocriptine / Q000008:administration & dosage / Q000627:therapeutic use*; D002819:Chorea / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use
D014149:Tranquilizing Agents; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine